Cargando…

High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis

Background: In China, less than one-fifth of multidrug-resistant tuberculosis (MDR-TB) cases are detected. MDR-TB screening is conducted amongst the following five high-risk groups of TB patients: chronic cases, close contacts of MDR-TB patients, patients with treatment failure, relapsed and returne...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhiqi, Zhou, Changming, Ning, Zhu, Lu, Wei, Zhao, Qi, Hu, Yi, Diwan, Vinod K., Xu, Biao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136353/
https://www.ncbi.nlm.nih.gov/pubmed/30203719
http://dx.doi.org/10.1080/16549716.2018.1500763
_version_ 1783354982007832576
author Yang, Zhiqi
Zhou, Changming
Ning, Zhu
Lu, Wei
Zhao, Qi
Hu, Yi
Diwan, Vinod K.
Xu, Biao
author_facet Yang, Zhiqi
Zhou, Changming
Ning, Zhu
Lu, Wei
Zhao, Qi
Hu, Yi
Diwan, Vinod K.
Xu, Biao
author_sort Yang, Zhiqi
collection PubMed
description Background: In China, less than one-fifth of multidrug-resistant tuberculosis (MDR-TB) cases are detected. MDR-TB screening is conducted amongst the following five high-risk groups of TB patients: chronic cases, close contacts of MDR-TB patients, patients with treatment failure, relapsed and returned patients, and smear-positive patients at the end of the third month of initial treatment. Objective: To estimate the possibility of detecting MDR-TB cases if only the high-risk screening strategy is applied in China. Methods: A secondary analysis was applied to the surveillance-based longitudinal data of all sputum smear-positive TB patients in Prefecture E and Prefecture W of China from 2013 to 2015. The population attributable risk (PAR) was estimated using odds ratios for five risk factors/predictors and exposure proportions amongst all MDR-TB cases. Results: A total of 3513 TB patients (2807 from Prefecture E and 706 from Prefecture W) were included. Males accounted for 77.91% (2737/3513) of the patients. The average age was 52.5 ± 20.0 years old. Overall, 40.34% (71/176) of MDR-TB patients were from the five high-risk groups during the three-year study period. The detected proportion of MDR-TB cases using the high-risk screening strategy was significantly higher in Prefecture E than in Prefecture W. The PAR% for all five risk factors/predictors was 43.4% (95% CI: 24.6–61.7%), 49.9% (95% CI: 31.3–67.0%), and 30.3% (95% CI: 12.9–50.1%) in Prefecture E and 36.6% (95% CI: 10.4–64.5%), 13.3% (95% CI: −1.7–39.7%), and −82.5% (95% CI: −117.5–−11.2%) in Prefecture W in 2013, 2014, and 2015, respectively. The PAR% for the five specific risk factors/predictors ranged from 0.4% (95% CI: −0.2–4.8%) to 21.0% (95% CI: 13.1–30.0%) in these two prefectures. Conclusion: In general, a high-risk screening strategy would miss more than half of the MDR-TB patients because they do not belong to the five high-risk groups.
format Online
Article
Text
id pubmed-6136353
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-61363532018-09-14 High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis Yang, Zhiqi Zhou, Changming Ning, Zhu Lu, Wei Zhao, Qi Hu, Yi Diwan, Vinod K. Xu, Biao Glob Health Action Original Article Background: In China, less than one-fifth of multidrug-resistant tuberculosis (MDR-TB) cases are detected. MDR-TB screening is conducted amongst the following five high-risk groups of TB patients: chronic cases, close contacts of MDR-TB patients, patients with treatment failure, relapsed and returned patients, and smear-positive patients at the end of the third month of initial treatment. Objective: To estimate the possibility of detecting MDR-TB cases if only the high-risk screening strategy is applied in China. Methods: A secondary analysis was applied to the surveillance-based longitudinal data of all sputum smear-positive TB patients in Prefecture E and Prefecture W of China from 2013 to 2015. The population attributable risk (PAR) was estimated using odds ratios for five risk factors/predictors and exposure proportions amongst all MDR-TB cases. Results: A total of 3513 TB patients (2807 from Prefecture E and 706 from Prefecture W) were included. Males accounted for 77.91% (2737/3513) of the patients. The average age was 52.5 ± 20.0 years old. Overall, 40.34% (71/176) of MDR-TB patients were from the five high-risk groups during the three-year study period. The detected proportion of MDR-TB cases using the high-risk screening strategy was significantly higher in Prefecture E than in Prefecture W. The PAR% for all five risk factors/predictors was 43.4% (95% CI: 24.6–61.7%), 49.9% (95% CI: 31.3–67.0%), and 30.3% (95% CI: 12.9–50.1%) in Prefecture E and 36.6% (95% CI: 10.4–64.5%), 13.3% (95% CI: −1.7–39.7%), and −82.5% (95% CI: −117.5–−11.2%) in Prefecture W in 2013, 2014, and 2015, respectively. The PAR% for the five specific risk factors/predictors ranged from 0.4% (95% CI: −0.2–4.8%) to 21.0% (95% CI: 13.1–30.0%) in these two prefectures. Conclusion: In general, a high-risk screening strategy would miss more than half of the MDR-TB patients because they do not belong to the five high-risk groups. Taylor & Francis 2018-09-11 /pmc/articles/PMC6136353/ /pubmed/30203719 http://dx.doi.org/10.1080/16549716.2018.1500763 Text en © 2018 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Yang, Zhiqi
Zhou, Changming
Ning, Zhu
Lu, Wei
Zhao, Qi
Hu, Yi
Diwan, Vinod K.
Xu, Biao
High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis
title High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis
title_full High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis
title_fullStr High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis
title_full_unstemmed High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis
title_short High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis
title_sort high-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of china: a drug susceptibility surveillance-based secondary data analysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136353/
https://www.ncbi.nlm.nih.gov/pubmed/30203719
http://dx.doi.org/10.1080/16549716.2018.1500763
work_keys_str_mv AT yangzhiqi highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis
AT zhouchangming highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis
AT ningzhu highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis
AT luwei highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis
AT zhaoqi highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis
AT huyi highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis
AT diwanvinodk highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis
AT xubiao highriskscreeninganddetectionofmultidrugresistanttuberculosisintwoprefecturesofchinaadrugsusceptibilitysurveillancebasedsecondarydataanalysis